A Study of BMS-986171 in Healthy People to Assess Safety, to Measure Blood Levels of Drug, and to Find Out What the Drug Does to the Body
| Status: | Recruiting |
|---|---|
| Conditions: | Gastrointestinal |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | 21 - 55 |
| Updated: | 7/28/2016 |
| Start Date: | October 2015 |
| End Date: | May 2017 |
| Contact: | Recruiting sites have contact information. Please contact the sites directly. If there is no contact information, please email: |
| Email: | Clinical.Trials@bms.com |
A Randomized, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986171 in Healthy Subjects
The purpose of this study is to assess safety, to measure blood levels of drug, and to find
out what the drug does to the body.
out what the drug does to the body.
For more information regarding BMS clinical trial participation, please visit
www.BMSStudyConnect.com
Inclusion Criteria:
- Age 21 to 55 years
- BMI 30-40 (Part A or Part B); BMI 20-35 (Part C). BMI = weight (kg)/ [height (m)]
Exclusion Criteria:
- Any significant medical illness
- Cannot tolerate subcutaneous injections, or having blood samples taken
- Smoking more than 10 cigarettes/day
- History of allergy to pegylated compounds or of hypersensitivity to protein based
therapeutics.
- HIV, Hepatitis B virus (HBV) or Hepatitis C virus (HCV) infection.
- Pregnancy
We found this trial at
1
site
Click here to add this to my saved trials
